- Research article
- Open Access
Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status
© Boysen et al; licensee BioMed Central Ltd. 2006
- Received: 22 December 2005
- Accepted: 27 April 2006
- Published: 27 April 2006
Natural killer (NK) cells in the cow have been elusive due to the lack of specific NK cell markers, and various criteria including a CD3-/CD2+ phenotype have been used to identify such cells. The recent characterization of the NK-specific NKp46 receptor has allowed a more precise definition of bovine NK cells. NK cells are known as a heterogeneous cell group, and we here report the first functional study of bovine NK cell subsets, based on the expression of CD2.
Bovine CD2- NK cells, a minor subset in blood, proliferated more rapidly in the presence of IL-2, dominating the cultures after a few days. Grown separately with IL-2, CD2- and CD2+ NK cell subsets did not change CD2 expression for at least two weeks. In blood, CD2- NK cells showed a higher expression of CD44 and CD25, consistent with a high activation status. A higher proportion of CD2- NK cells had intracellular interferon-gamma in the cytoplasm in response to IL-2 and IL-12 stimulation, and the CD2- subset secreted more interferon-gamma when cultured separately. Cytotoxic capacity was similar in both subsets, and both carried transcripts for the NK cell receptors KIR, CD16, CD94 and KLRJ. Ligation by one out of two tested anti-CD2 monoclonal antibodies could trigger interferon-gamma production from NK cells, but neither of them could alter cytotoxicity.
These results provide evidence that bovine CD2- as well as CD2+ cells of the NKp46+ phenotype are fully functional NK cells, the CD2- subset showing signs of being more activated in the circulation.
- Natural Killer Cell
- Human Natural Killer Cell
- Natural Killer Cell Function
- Natural Killer Cell Receptor
- Natural Killer Cell Subset
Natural killer cells were initially defined as a heterogeneous population of large granular lymphocytes that were able to spontaneously kill target cells. Human natural killer cells were later phenotypically defined as CD3-/CD56+ lymphocytes , and can be divided into distinct functional subsets, the CD56bright being mainly cytokine producers and CD56dim being more effective killers . Mice and rats do not express CD56 on haematopoietic cells; thus NK cells in these species are instead defined as non-T lymphocytes bearing NKR-P1 molecules , although the use of NKp46 as the standard NK cell identifier in the rat has been suggested . There is less evidence for a clear functional division of NK cells in rodents . Criteria for the definition of NK cells have not been clarified in most farm animal species . In the cow, NK-like cells have been described as CD3-/CD2+ lymphocytes [7–10], and NK-like cells have been isolated on the basis of markers not commonly expressed by NK cells . Recently, the characterization of bovine NKp46 (CD335) enabled a more precise identification of bovine NK cells . The NKp46 receptor has been proposed as the most accurate marker for human NK cells , as it is highly NK-restricted and uniformly expressed by cultured as well as resting NK cells [14–16].
The CD2 molecule is known as an adhesion molecule as well as a receptor for activation on both NK cells and T-cells, reviewed in . In the cow, CD2 is frequently used as a cell marker in cellular immunology, and several anti-bovine CD2 monoclonal antibodies (mAbs) have been described [18, 19]. The functional role of CD2 in bovine NK cells has not been previously studied, but NKp46+ cells in cattle peripheral blood can be divided into distinct CD2+ and CD2- phenotypes, the latter typically comprising around 20% of the cells . Similar proportions have been reported in human blood [20, 21], but only a few studies have been published that functionally describe CD2- NK cells from blood in healthy humans [22–24]. There does not seem to be a strong difference in expression of CD2 between the human CD56bright and CD56dim NK cell subsets . In the mouse, CD2- cells has been associated with immature cell stages , but blocking and knock-out experiments have shown that CD2 is not necessary for well-developed NK cell function [25, 26]. Accordingly, CD2 has been classified as a co-receptor , although the use of this term has been questioned, since apparently no known activating NK cell receptor stand out as dominating, unlike in T-cells .
The scope of the present study was to investigate bovine NK cell subsets, defined by CD2 expression. Our results show that both subsets are fully capable of NK cell activity, and blocking experiments confirm a redundancy of CD2 for NK cell function. Furthermore, the CD2- subset is more activated in circulation and show a stronger proliferative and interferon-gamma (IFN-γ) producing capacity.
CD2 expression in peripheral blood and IL-2 activated NK cells
To elucidate the proliferation of these subsets, NK cells were stained with the cell division marker carboxyfluorescein diacetate succinimidyl ester (CFSE) on the day after isolation, and cultured in the presence of rbIL-2, using quiescent NK cells as controls . Three days later, the CD2-/low subset had decreased more in CFSE intensity than the CD2+ subset, indicating that the former subset had proliferated more vigorously (Fig. 1B). However, after six days in culture, CFSE intensity in the two subsets were almost similar, indicating that CD2+ NK cells entered proliferation at a later stage than the CD2-/low cells.
To further clarify if the CD2+ and CD2-/low cells were distinct subsets, NK cells were divided by immunomagnetic beads into CD2 expressing and non-expressing subsets the day after NK cell isolation, and cultured in rbIL-2 containing medium for ten consecutive days. Throughout this period, no major change of the expression of CD2 was observed (Fig. 1C). The tendency of a low CD2 expression on part of the CD2- subset, as seen with non-separated cells, was not clear in these separated cell cultures. A frequent observation made was that the CD2-depleted NK cells entered an exponential growth phase at an earlier stage than the CD2 selected cells, in accordance with the CFSE labelling results.
Phenotype of CD2-defined subsets of NK cells in peripheral blood and following IL-2 activation
Following isolation and culture of bovine NK cells for five days in the presence of rbIL-2, differences between the subsets became less clear (Fig. 2B). At this time CD44 and CD25 were clearly upregulated and expressed by almost all NK cells, CD11c and CD45RO were slightly upregulated while CD11b remained unchanged. CD44 remained clearly brighter on the CD2-/low subset and CD11c slightly brighter on the CD2+ subset.
Following 12 days in rbIL-2 culture, a further upregulation in both subsets was seen for CD44 (intensely bright), CD45RO and CD25, while CD11c had decreased, and CD11b remained unchanged (Fig. 2C). At this time, differences between the CD2-/low and CD2+ subsets were not readily distinguishable. After three weeks, as primary NK cell cultures started to show reduced viability, a similar phenotype pattern was seen, although CD44 and CD45RO expression was even further increased in all NK cells (not shown).
Evaluation of mRNA expression of NK receptor genes in CD2- and CD2+ NK cell subsets
IFN-γ production by CD2- and CD2+ NK cell subsets in peripheral blood and culture
IFN-γ secretion by rbIL-2 activated NK cell subsets was assessed by separating NK cells into CD2- and CD2+ subsets and cultured for one week as described above. Following 24 hrs further incubation in the absence or presence of rbIL-12, the level of IFN-γ in the supernatant was measured in an ELISA. In the presence of rbIL-12, the CD2-/low subset produced from 10 to 300% more IFN-γ than CD2+ cells (Fig. 4B). IFN-γ production in the absence of rbIL-12 was negligible (< 1 ng/ml) by both subsets, and were subtracted as baseline levels in the calculation of these responses. The expression of CD2 was unchanged during this period, as shown above.
Cytotoxicity of CD2- and CD2+ NK cell subsets
Effect of anti-CD2 mAbs on IFN-γ response from NK cells
The ability of CD2 cross-linking to trigger IFN-γ production from NK cells was assessed by culturing NK cells for 24 hours in plastic wells pre-coated with anti-CD2 mAbs, followed by measuring IFN-γ in the supernatants. In wells coated with one of the two tested anti-CD2-mAbs (mAb II, MUC2a), an IFN-γ response was measured, while in wells coated with the other (mAb I, BAQ95A), no response above background could be measured (Fig. 5A). This response occurred without rbIL-12, but was potentiated by the presence of this cytokine. The IFN-γ response by anti-NKp46 mAb was similar to previously obtained results , and was always higher than the anti-CD2 induced response. No IFN-γ above medium controls was measured with mAbs against CD8, which is present on most cultured NK cells , indicating that the response seen with MUC2A was CD2-specific.
Effect of anti-CD2 mAbs on NK cytotoxicity
Available anti-bovine CD2 mAbs have not been previously tested for their ability to activate or inhibit NK cell cytotoxicity. To investigate this, bovine NK cells were pre-treated with the same two mAbs as mentioned above, and tested for interference with NK cytotoxicity in 51Cr release assays. Neither of these mAbs could alter the NK cytotoxicity against the bovine target cell lines BL-3.1 (Fig. 5B) or MDBK (Fig. 5C), while anti-NKp46 blocked most of the killing. A similar result was obtained with the target KN-31 using NK cells from two animals (not shown). No induction of redirected lysis was seen with the P815 target (Fig. 5D), while anti-NKp46 did, like previously reported .
The recent characterization of bovine NK cells  allows this important field of innate immunity to be studied in the cow. Human NK cells can be divided into functional subsets depending on the level of CD56 expression, but like in rats and mice, this antigen is probably not present on NK cells in the cow , thus not allowing a direct comparison with the human subsets. However, CD2 expression divides bovine NK cells into two distinct populations , and the scope of the present study was to examine CD2+ and CD2- bovine NK cell subsets for functional properties and status of activation.
Around 20% of NK cells in peripheral blood of cattle did not express CD2, similar to findings in man [20, 21]. During two weeks of primary culture with IL-2, the NK cell population changed towards a dominance of the CD2- phenotype. This change tended to be more pronounced in young animals, but was also present in adults. No intermediate forms were seen at any point, indicating that the two subsets were discretely preserved. However, under these unfractioned culturing conditions, the initial CD2- population appeared to acquire a low density of CD2 receptors. In contrast, no such CD2 acquisition was seen when CD2- NK cells were cultured separately. More detailed studies would be required to explain this phenomenon, but a conceivable hypothesis could be intercellular exchange of receptors during cell culture, as recently demonstrated . We have consequently chosen to name these subsets CD2-/low and CD2+ when cultured in the presence of IL-2. IL-2 is reported to upregulate CD2 on human NK cells; partly as a minor intensity increase like observed here, but also as a proportional increase of the CD2+ population [16, 22], unlike our findings. Species differences may explain these conflicting proliferation patterns.
Interestingly, the CD2- subset contained the highest relative numbers of IFN-γ+ NK cells following cytokine stimulation, and IFN-γ secretion to the supernatant was also stronger following IL-2 stimulation. To our knowledge, experiments showing IFN-γ responses from corresponding subsets have not been reported in other species. Both subsets were cytotoxic against conventional target cells, the CD2-/low most often, but not always, being the most effective killers. These findings are in agreement with reports from human NK cells where both subsets were comparably cytotoxic . We conclude that both subsets had fully developed natural killer cell functions, the CD2-/low NK cells being the more effective IFN-γ producers.
To identify appropriate activation markers in bovine NK cells we analyzed antigens known to be upregulated on other activated bovine lymphocytes [8, 33]. We observed IL-2-induced upregulation of CD25, CD44 and CD45RO, in accordance with reports from human NK cells [34–37]. The unchanged CD11b expression and slight but transient CD11c upregulation in IL-2 culture was also similar to human NK cells .
In peripheral blood NK cells, two of the investigated markers (CD44 and CD25) were highest on CD2- subset. Expression of CD25 on NK cells has been associated with higher proliferative potential , providing support for the increased proliferation of the CD2- subset seen here. CD2, CD44 as well as the integrins are associated with cell adhesion, and notably, CD44 has been associated with binding to high endothelial venules . Hence, the differential expression of these as well as CD11c on NK cell subsets could possibly relate to adhesive and/or migratory properties, although it has been warned against inferring in vivo migratory properties based on the expression of adhesion molecules alone .
In contrast to CD44 and CD25, CD45RO was moderately brighter on the CD2+ subset. Increased expression of CD45RO has been reported to be a transient phenomena in human NK cells upon activation [37, 40]. , but the role of this molecule in NK cells remains unclear [41, 42]. It is noteworthy that in parallel to our findings with NK cells, bovine gamma delta (γδ) T-cells have been reported to express more CD44 and less CD45 in a CD2- subset, although it was not stated which isoform of CD45 that was targeted . Furthermore, human peripheral CD2-/low T-cells were recently reported to show greater proliferative capacity as well as CD45RO expression, unlike CD2+ T-cells; these were interpreted to be immature T-cells . They were by definition CD3+, and therefore of a different lineage, but also in NK cells the lack of CD2 expression has been linked to immaturity [5, 22]. The knowledge of NK cell development is still limited, but definition criteria for differentiation stages have recently been suggested . According to those, the CD2- subset presented here would qualify as mature NK cells since they show full cytotoxicity and IFN-γ production. The findings that they comprise up to 30% of circulating NK cells and express all NK receptors investigated on the mRNA level would appear paradoxical if they represent immature stages. Further studies would be required to target such aspects.
To complement these studies on NK cell subsets defined by CD2 expression, we examined the role of the CD2 molecule itself on bovine NK cells, by employing two bovine anti-CD2 mAbs in functional NK cell assays. Cross-linking by one of the mAbs induced a clear IFN-γ response, similar to studies in human NK cells . Neither of the tested mAbs blocked cytotoxicity against NK-susceptible targets, and they did not induce redirected lysis of an FcR-bearing target. In human NK cells, significant blocking of cytotoxicity by CD2 mAbs usually does not occur , and no redirected lysis effect was observed , although cross-linking by conjugated mAbs against different epitopes could trigger cytotoxicity [48–50]. Similar observations have been done in mice . The human CD2 molecule has later been shown to contain a continuum of overlapping epitopes, to which different mAbs may bind with various degrees of functional interference . On this background, our experiments cannot exclude a CD2 function in cytotoxicity. Nevertheless, one CD2 mAb that apparently bound to a reactive epitope, since it could trigger IFN-γ production, did not affect target lysis. Together with the observation that CD2- NK cells were fully cytotoxic and produced IFN-γ, we conclude that, similar to other species, the CD2 molecule is not necessary for bovine NK cell function.
Bovine NK or NK-like cells have sometimes been defined as CD3-/CD2+ lymphocytes [7–9]. This may partly have been founded on reports that bovine PBMCs expressing CD2 were more cytotoxic than CD2- PBMCs . However, due to lack of NK-specific markers, those results could not be adjusted for the relative content of NK cells within each population. Our studies show that most NK cells in blood are CD2+. Considering that the majority of PBMCs do not express CD2, the proportion of CD2- NK cells would constitute only a small fraction of this population, hence providing a likely explanation for the cytotoxicity pattern shown by Campos et al. . Furthermore, in a report where CD3-/CD2+ cells were classified as NK cells, CD3-/CD2-lymphocytes were reported as a not previously described "null cell" population . Our present and previous studies  should provide evidence that these were most likely NK cells. In conclusion, we find that NK cell definitions based on a CD2+ phenotype exclude an important subset of bovine NK cells.
We have demonstrated here that CD2- and CD2+ subsets of bovine NK cells in peripheral blood have distinct phenotypic and functional properties, both subsets fulfilling criteria for being natural killer cells. The CD2- subset of NK cells show phenotypical signs of being more activated, both obtained from blood and during the first days of IL-2 culture, they are better IFN-γ producers and have higher proliferative capacity. Both subsets are cytotoxic and carry mRNA transcripts for a set of common NK cell receptors. One anti-CD2-mAb could incite an IFN-γ response from bovine NK cells, but no alteration of cytotoxicity was found by two tested mAbs. The results presented here establish NKp46+/CD2- cells as a distinct, activated and fully functional subset of NK cells in the cow, with a particular capacity for IFN-γ production.
Isolation and culture of bovine NK cells and subsets
Clinically healthy Norwegian Red dairy cattle of both sexes and of different ages above 3 months were used in this study. Blood samples were collected in tubes with EDTA as anticoagulant. Peripheral blood mononuclear cells (PBMC) were obtained by density gradient centrifugation using Lymphoprep (Axis-Shield, Oslo, Norway). NK cells were isolated and cultured as previously described . Briefly, PBMC were positively selected using mAb against NKp46 (CD335) (AKS1;IgG1; Serotec, Oxford, UK) and immunomagnetic anti-mouse pan IgG beads (Dynal, Oslo, Norway), and cultured in RPMI medium supplemented with 60μg/ml penicillin, 100 μg/ml streptomycin, 1 mM sodium pyruvate, non-essential amino acids, 50μM 2- mercaptoethanol (all GIBCO, Invitrogen) with 10% FCS and 100 U/ml rbIL-2, produced as described below. After 24–48 h, beads had undergone spontaneous detachment and were magnetically removed. Selection of NK cell subsets was performed after 24 h, by applying the anti-CD2 mAb MUC2A (VMRD, Pullman, WA, USA) and MACS anti-mouse IgG MicroBeads and LS columns (both Miltenyi Biotech, Bergish Gladbach, Germany) according to the manufacturer's instructions. To enhance purity, positive selection was repeated using a new LS column, and depletion repeated using an LD column. NK cells or subsets were cultured further for the appropriate length of time in rbIL-2-containing medium.
Two- or three-coloured flow cytometric analysis of surface receptors was performed on whole blood samples or cultured cells, as previously described , using the following antibodies: CD2 (MUC2A;IgG2a, BAQ95A;IgG1, or B26A4;IgM), CD11b (BAQ147A;IgM), CD11c (BAQ153A;IgM), CD25 (CACT108A;IgG2a), CD44 (BAG40A;IgG3), CD45RO (GC44A;IgG3) (all from VMRD), and NKp46 (AKS1). Subtype-specific secondary antibodies were conjugated with FITC or PE (Southern Biotech, Birmingham, AL, USA), or with Alexa Fluor 488 or Alexa Fluor 633 (Molecular Probes, Invitrogen). The samples were analyzed on a FACS CALIBUR flow cytometer (Becton Dickinson), equipped with Cell-Quest Pro software. 5 × 104 viable cells as gated in the forward side scatter plot were analyzed.
CFSE proliferation analysis
For cell proliferation studies, positively selected NK cells cultured for 20 h in the presence of rbIL-2 were incubated with 5 μM CFSE in PBS with 0.2% BSA for 10 min followed by addition of 5 ml cold RPMI and incubation on ice for 5 min. The cells were washed three times in RPMI and cultured in the presence of 100 U/ml rbIL-2 as described above. To obtain non-proliferating NK cells as controls, rbIL-2 was added at 1U/ml to washed NK cells; this amount was obtained by titrating rbIL-2 to an amount that kept the cells viable, but non-proliferating, as measured by cell counting and incorporation of 3H labeled thymidine.
Detection of intracellular and secreted IFN-γ
Bovine PBMCs were analyzed for IFN-γ producing cells as described previously , with modifications. Briefly, heparinized whole blood was incubated overnight in the absence or presence of rbIL-2 (200 U/ml), or rbIL-12 (5 U/ml) (kindly provided by Jayne Hope, Institute of Animal Health, Compton, UK). Twelve hours before harvesting, Brefeldin A (10 μg/ml) (Sigma) was added. PBMC were isolated by density gradient centrifugation and surface labelling was performed with mAbs against NKp46 (AKS1) and CD2 (MUC2A), and following permeabilization and fixation the anti-bovine IFN-γ mAb clone 6.6 (IgG2b) was applied (kindly provided by Gregers Jungersen, Danish Institute for Food and Veterinary Research, Copenhagen). 105 cells per sample were analyzed in a flow cytometer as described above.
For assessment of secreted IFN-γ, NK cell subsets pre-cultured for one week in the presence of rbIL-2 were incubated for 24 h in triplicates of 105, in the presence or absence of 0.5 U/ml rbIL-12. To assess the ability of mAb-ligation of the CD2 receptor to trigger IFN-γ production, NK cells were cultured in triplicates of 2 × 105 in 96-well MaxiSorp plates (NUNC, Denmark) pre-coated overnight in 0.05 M carbonate buffer (pH 9.6) with either of two anti-CD2 mAbs (MUC2A, BAQ95A), with anti-NKp46 mAb (AKS1), anti-CD8 mAb (BAQ111A;IgM) or none. In both types of experiment, medium was always containing 100U/ml rbIL-2. IFN-γ production in the supernatants was assessed using an ELISA (Bovine IFN-γ EASIA, Biosource, Nivelles, Belgium) according to the manufacturer's instructions. Concentrations were calculated from a standard curve made using purified bovine IFN-γ, kindly provided by Dr Stephen Jones (Pfizer, Melbourne, Australia).
NK cell cytotoxicity assays
The cytotoxic capacity of IL-2 activated bovine NK cells or subsets was tested in a standard 51Cr release assay as previously described , using the bovine target cell lines MDBK, BL3.1 or KN-31 (generic calf kidney cell line) or murine P815. The BL3.1 line is MHC class I-impaired, thus potentially devoid of important NK-cell inhibitory ligands , while P815 expresses Fcγ-receptors, allowing reverse antibody linking for redirected lysis. Specific 51Cr release was calculated on the basis of the ratio [(sample release – spontaneous release)/(total release – spontaneous release)] and lytic units (LU) were calculated as the capacity to kill 20% of targets contained within 107 effectors, as described by Bryant and colleagues . In redirected lysis assays, the effector cells were preincubated for 20–30 min with 1 μg/ml of mAbs against NKp46 (AKS1), CD8 (CACT80C) or CD2 (BAQ95A) (all IgG1).
Expression of recombinant bovine interleukin-2
As bovine NK cells do not proliferate in response to human IL-2 [11, 12], bovine rbIL-2 was produced as follows: mRNA was isolated from conA stimulated bovine PBMC with Dynabeads Oligo (dT)25 (Dynal) and cDNA was synthesized by SuperScript™ II RNase H- Reverse Transcriptase using oligo (dT)12–18 (both Invitrogen) The coding region of bovine IL-2 [GenBank: M12791]  was amplified by PCR using PfuUltra™ High-Fidelity DNA Polymerase (Stratagene, La Jolla, CA) and gene-specific primers with BamHI and XhoI restriction sites: 5' GGATCCTCAACTCCTGCCACAATGTA 3' and 5' CTCGAGTTAAGACTAACAGTTACAAAAGGT 3'. The PCR product was purified by agarose gel electrophoresis and QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany), incubated with Taq DNA polymerase (Invitrogen), cloned into pCR® 2.1-TOPO Vector (Invitrogen), released by BamHI and XhoI digestion and subcloned into pcDNA I (Invitrogen). The correctness of this construct was verified by sequencing. 20 μg of plasmid DNA was mixed with 120 μl Lipofectamine (Invitrogen) in 2.8 ml Opti-MEM (Invitrogen) and incubated for 20–30 min at room temperature. 11.2 ml Opti-MEM were then added and the mixture transferred to a 160-cm2 flask containing a 70% confluent layer of 293T cells that had been washed three times with Opti-MEM. After 6 h, 14 ml of RPMI 1640 medium/20% FCS (Invitrogen) was added. After another 6 h, cells were washed twice in HBSS (Invitrogen) and RPMI/10 % FCS was added. The medium, containing rbIL-2, was harvested twice within three days, sterile filtered and assayed in an IL-2 bioassay based on proliferation of 4 days ConA stimulated PBMC as measured by 3H labeled thymidine incorporation. 1 U is defined as the amount of IL-2 inducing half the maximal proliferation of ConA blasts. The supernatant contained 10000 U rbIL-2/ml, was stored at -20°C, and was used without further purification at the described concentrations.
Detection of gene expression
The expression of several NK cell receptors was detected in CD2+ and CD2- NK cell subsets by reverse transcriptase PCR. mRNA was harvested by μMACS mRNA Isolation Kit (Miltenyi Biotech) from 0.5–1 × 107cells and cDNA was synthesized by SuperScript™ III RNase H- Reverse Transcriptase using oligo (dT)12–18. The amount of cDNA template was measured using NanoDrop spectrophotometer (NanoDrop, Wilmington, DE, USA). Intron spanning primers generating products of about 500 bp were designed based on sequences previously described [29, 30]. NKp46 forward: 5' GAGCGATGCCTTCCACACTTGC 3' and reverse 5' GGTTGTTGTAGGAGCCAAAGCATCTGT 3'; annealing temperature 68°C, CD16: forward 5' GTGGTGGCACAATGGGAC 3' and reverse 5' GCCATCCCTCCATTCCTC 3', annealing temp. 62°C; KIR: forward 5' AATGTGACCCTCCGCTGTC 3' and reverse 5' AACAGTGGGTCGCTGGAGT 3', annealing temp. 64°C; CD94/KLRD1: forward 5' CCTTGTGTTGATGGCTGCTT 3' and reverse 5' AAAATCCTTCCTCTTGGGTT 3' annealing temp. 58°C; KLRJ forward 5' TGTGGATTCTTTGGTTACCAG 3' and reverse 5' TGAGGCCAGAAGGAAGAGAA 3' annealing temp. 59°C; GAPDH forward AGTGGGGTGATGCTGGTGCT, reverse TCCAGGCGGCAGGTCA, annealing temp. 66°C (477bp product). 600 ng of cDNA was added to three parallel PCR reactions run at 20, 25 or 30 cycles with Dynazyme (Finnzymes, Espoo, Finland). Initial analysis revealed that NKp46 was equally expressed in both NK cell subsets in comparision to GAPDH (not shown), and its surface expression was also at equal levels. Intensity of PCR products was determined using NKp46 as a reference gene, using KODAK 1D Image Analysis software (Eastman Kodak, New Haven, CT, USA).
We wish to thank Jayne C. Hope (Institute for Animal Health, Compton, UK) for providing rbIL-12, Gregers Jungersen (Danish Institute for Food and Veterinary Research, Copenhagen, Denmark) for providing anti-bovine IFN-γ mAb and Dr Stephen Jones (Pfizer, Melbourne, Australia) for providing rbIFN-γ. Finally we thank Erik Dissen (Institute of Basic Medical Sciences, University of Oslo) for critical reading of this manuscript. This work was carried out under grant support from the Norwegian Research Council.
- Hercend T, Schmidt RE: Characteristics and uses of natural killer cells. Immunol Today. 1988, 9: 291-293. 10.1016/0167-5699(88)91317-5.View ArticlePubMedGoogle Scholar
- Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22: 633-640. 10.1016/S1471-4906(01)02060-9.View ArticlePubMedGoogle Scholar
- Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE: Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol. 1992, 149: 1631-1635.PubMedGoogle Scholar
- Westgaard IH, Berg SF, Vaage JT, Wang LL, Yokoyama WM, Dissen E, Fossum S: Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta. J Leukoc Biol. 2004, 76: 1200-1206. 10.1189/jlb.0903428.View ArticlePubMedGoogle Scholar
- Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer?. Nat Rev Immunol. 2003, 3: 413-425. 10.1038/nri1088.View ArticlePubMedGoogle Scholar
- Evans DL, Jaso-Friedmann L: Natural killer (NK) cells in domestic animals: phenotype, target cell specificity and cytokine regulation. Vet Res Commun. 1993, 17: 429-447. 10.1007/BF01839211.View ArticlePubMedGoogle Scholar
- Goff WL, Johnson WC, Horn RH, Barrington GM, Knowles DP: The innate immune response in calves to Boophilus microplus tick transmitted Babesia bovis involves type-1 cytokine induction and NK-like cells in the spleen. Parasite Immunol. 2003, 25: 185-188. 10.1046/j.1365-3024.2003.00625.x.View ArticlePubMedGoogle Scholar
- Koo HC, Park YH, Hamilton MJ, Barrington GM, Davies CJ, Kim JB, Dahl JL, Waters WR, Davis WC: Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves. Infect Immun. 2004, 72: 6870-6883. 10.1128/IAI.72.12.6870-6883.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Sordillo LM, Kendall JT, Corl CM, Cross TH: Molecular characterization of a saposin-like protein family member isolated from bovine lymphocytes. J Dairy Sci. 2005, 88: 1378-1390.View ArticlePubMedGoogle Scholar
- Campos M, Rossi CR, Bielefeldt Ohmann H, Beskorwayne T, Rapin N, Babiuk LA: Characterization and activation requirements of bovine lymphocytes acquiring cytotoxic activity after interleukin-2 treatment. Vet Immunol Immunopathol. 1992, 32: 205-223. 10.1016/0165-2427(92)90047-T.View ArticlePubMedGoogle Scholar
- Endsley JJ, Endsley MA, Estes DM: Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J Leukoc Biol. 2006, 79: 71-79. 10.1189/jlb.0505239.View ArticlePubMedGoogle Scholar
- Storset AK, Kulberg S, Berg I, Boysen P, Hope JC, Dissen E: NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur J Immunol. 2004, 34: 669-676. 10.1002/eji.200324504.View ArticlePubMedGoogle Scholar
- Moretta L, Bottino C, Pende D, Vitale M, Mingari MC, Moretta A: Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett. 2005, 100: 7-13. 10.1016/j.imlet.2005.07.004.View ArticlePubMedGoogle Scholar
- Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A: p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 1997, 186: 1129-1136. 10.1084/jem.186.7.1129.PubMed CentralView ArticlePubMedGoogle Scholar
- Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A: NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 1999, 29: 1656-1666. 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1.View ArticlePubMedGoogle Scholar
- Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006, 107: 159-166. 10.1182/blood-2005-04-1351.PubMed CentralView ArticlePubMedGoogle Scholar
- McNerney ME, Kumar V: The CD2 family of natural killer cell receptors. Curr Top Microbiol Immunol. 2006, 298: 91-120.PubMedGoogle Scholar
- Davis WC, Splitter GS: Individual antigens of cattle. Bovine CD2 (BoCD2). Vet Immunol Immunopathol. 1991, 27: 43-50. 10.1016/0165-2427(91)90077-P.View ArticlePubMedGoogle Scholar
- Davis WC, Ellis JA, Machugh ND, Baldwin CL: Bovine pan T-cell monoclonal antibodies reactive with a molecule similar to CD2. Immunology. 1988, 63: 165-167.PubMed CentralPubMedGoogle Scholar
- Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J: Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol. 1990, 145: 3194-3201.PubMedGoogle Scholar
- Lima M, Teixeira MA, Queiros ML, Leite M, Santos AH, Justica B, Orfao A: Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis. 2001, 27: 731-743. 10.1006/bcmd.2001.0443.View ArticlePubMedGoogle Scholar
- Nakazawa T, Agematsu K, Yabuhara A: Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology. 1997, 92: 180-187. 10.1046/j.1365-2567.1997.00343.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Cordero OJ, Sarandeses C, Lopez-Rodriguez JL, Nogueira M: The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha. Immunopharmacology. 1995, 29: 215-223. 10.1016/0162-3109(95)00057-Z.View ArticlePubMedGoogle Scholar
- Manara GC, Ferrari C, Pagani L, Sansoni P, Bologna G, Molinari A, Torresani C, De Panfilis G: Morphometric evaluation of CD16-positive cells with respect to CD2 antigen coexpression. Cell Immunol. 1990, 128: 118-129. 10.1016/0008-8749(90)90011-F.View ArticlePubMedGoogle Scholar
- Nakamura T, Takahashi K, Fukazawa T, Koyanagi M, Yokoyama A, Kato H, Yagita H, Okumura K: Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. J Immunol. 1990, 145: 3628-3634.PubMedGoogle Scholar
- Sasada T, Reinherz EL: A critical role for CD2 in both thymic selection events and mature T cell function. J Immunol. 2001, 166: 2394-2403.View ArticlePubMedGoogle Scholar
- Lanier LL, Corliss B, Phillips JH: Arousal and inhibition of human NK cells. Immunol Rev. 1997, 155: 145-154. 10.1111/j.1600-065X.1997.tb00947.x.View ArticlePubMedGoogle Scholar
- Warren HS, Kinnear BF: Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation. J Immunol. 1999, 162: 735-742.PubMedGoogle Scholar
- Storset AK, Slettedal IO, Williams JL, Law A, Dissen E: Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs. Eur J Immunol. 2003, 33: 980-990. 10.1002/eji.200323710.View ArticlePubMedGoogle Scholar
- Collins RA, Gelder KI, Howard CJ: Nucleotide sequence of cattle FcGRIII: its identification in gammadelta T cells. Immunogenetics. 1997, 45: 440-443. 10.1007/s002510050228.View ArticlePubMedGoogle Scholar
- Boysen P, Klevar S, Olsen I, Storset AK: The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts. Infect Immun. 2006, 74: 953-960. 10.1128/IAI.74.2.953-960.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Vanherberghen B, Andersson K, Carlin LM, Nolte-'t Hoen EN, Williams GS, Hoglund P, Davis DM: Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells. Proc Natl Acad Sci USA. 2004, 101: 16873-16878. 10.1073/pnas.0406240101.PubMed CentralView ArticlePubMedGoogle Scholar
- Vesosky B, Turner OC, Turner J, Orme IM: Activation marker expression on bovine peripheral blood gammadelta T cells during post-natal development and following vaccination with a commercial polyvalent viral vaccine. Dev Comp Immunol. 2003, 27: 439-447. 10.1016/S0145-305X(02)00134-9.View ArticlePubMedGoogle Scholar
- Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J: Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 1990, 171: 1509-1526. 10.1084/jem.171.5.1509.View ArticlePubMedGoogle Scholar
- Nagler A, Lanier LL, Phillips JH: Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med. 1990, 171: 1527-1533. 10.1084/jem.171.5.1527.View ArticlePubMedGoogle Scholar
- Uksila J, Salmi M, Butcher EC, Tarkkanen J, Jalkanen S: Function of lymphocyte homing-associated adhesion molecules on human natural killer and lymphokine-activated killer cells. J Immunol. 1997, 158: 1610-1617.PubMedGoogle Scholar
- Braakman E, Sturm E, Vijverberg K, van Krimpen BA, Gratama JW, Bolhuis RL: Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cells. Int Immunol. 1991, 3: 691-697.View ArticlePubMedGoogle Scholar
- Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, Gunsilius E: Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology. 2003, 207: 85-93. 10.1078/0171-2985-00219.View ArticlePubMedGoogle Scholar
- Westermann J, Walter S, Nagahori Y, Heerwagen C, Miyasaka M, Pabst R: Blood leucocyte subsets of the rat: expression of adhesion molecules and localization within high endothelial venules. Scand J Immunol. 1996, 43: 297-303.View ArticlePubMedGoogle Scholar
- Warren HS, Skipsey LJ: Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. Immunology. 1991, 74: 78-85.PubMed CentralPubMedGoogle Scholar
- Yamada H, Kishihara K, Kong YY, Nomoto K: Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice. J Immunol. 1996, 157: 1523-1528.PubMedGoogle Scholar
- Holmes N: CD45: all is not yet crystal clear. Immunology. 2006, 117: 145-155. 10.1111/j.1365-2567.2005.02265.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Loza MJ, Luppi P, Kiefer K, Martin ES, Szczytkowski JL, Perussia B: Human peripheral CD2-/lo T cells: an extrathymic population of early differentiated, developing T cells. Int Immunol. 2005, 17: 1213-1225. 10.1093/intimm/dxh298.View ArticlePubMedGoogle Scholar
- Vosshenrich CA, Samson-Villeger SI, Di Santo JP: Distinguishing features of developing natural killer cells. Curr Opin Immunol. 2005, 17: 151-158. 10.1016/j.coi.2005.01.005.View ArticlePubMedGoogle Scholar
- Mason A, Bernard A, Smyth MJ, Ortaldo JR: Role of CD2 in regulation of CD3- LGL function. Eur Cytokine Netw. 1991, 2: 31-37.PubMedGoogle Scholar
- Chan WC, Ye G, Link S, Mawle AC, Nicholson JK: CD2 and other surface molecules in the regulation of non-MHC-restricted cytolytic function. Immunology. 1989, 67: 56-61.PubMed CentralPubMedGoogle Scholar
- Lanier LL, Ruitenberg JJ, Phillips JH: Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988, 141: 3478-3485.PubMedGoogle Scholar
- Siliciano RF, Pratt JC, Schmidt RE, Ritz J, Reinherz EL: Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature. 1985, 317: 428-430. 10.1038/317428a0.View ArticlePubMedGoogle Scholar
- Bolhuis RL, Roozemond RC, van de Griend RJ: Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. J Immunol. 1986, 136: 3939-3944.PubMedGoogle Scholar
- Schmidt RE, Schlossman SF, Reinherz EL, Ritz J: Activation of natural killer function through the T11/E rosette receptor. Haematol Blood Transfus. 1987, 31: 347-350.PubMedGoogle Scholar
- Damschroder MM, Kozhich AA, Woods RM, Cheng L, Mullikin BA, Wilson SD, Ulbrandt ND, Bachy CM, Wu H, Suzich JA, Kiener PA, Dall'Acqua WF, White WI: Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies. Mol Immunol. 2004, 41: 985-1000.View ArticlePubMedGoogle Scholar
- Olsen I, Boysen P, Kulberg S, Hope JC, Jungersen G, Storset AK: Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70. Infect Immun. 2005, 73: 5628-5635. 10.1128/IAI.73.9.5628-5635.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Harms JS, Splitter GA: Impairment of MHC class I transcription in a mutant bovine B cell line. Immunogenetics. 1992, 35: 1-8. 10.1007/BF00216620.View ArticlePubMedGoogle Scholar
- Bryant J, Day R, Whiteside TL, Herberman RB: Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods. 1992, 146: 91-103. 10.1016/0022-1759(92)90052-U.View ArticlePubMedGoogle Scholar
- Cerretti DP, McKereghan K, Larsen A, Cantrell MA, Anderson D, Gillis S, Cosman D, Baker PE: Cloning, sequence, and expression of bovine interleukin 2. Proc Natl Acad Sci USA. 1986, 83: 3223-3227.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.